KPG-121

N/A

Report date: 2024/11/06 14:35:08
NME

Base Information

Drug NameKPG-121
Drug Alias NameKPG-121
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCasein kinase I isoform alpha degradersDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders
TargetsCasein kinase I isoform alphaDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsMyelodysplastic SyndromesProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKangpu Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKangpu Biomedical Technology Co LtdKangpu Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A